Caring for all by caring for one. Founded in the science of precision medicine, we are developing a portfolio of drugs to modulate the activity of proteins responsible for rare diseases with the potential to translate these findings into common diseases. Full website with job postings coming soon. SCIENTIFIC FOUNDERS: David B. Goldstein and John G. McHutchison INVESTORS: Droia Ventures, EcoR1 Capital, Deerfield, and Osprey Impact CONTACT: info@actiobio.com ©Actio Biosciences